Fresenius Medical Care AG (MEX:FME N) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FME N Fresenius Medical Care AG MEX:FME N
48 GF Score
Price MXN778.14
GF Value MXN1,670.07
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG FFO per Share?

FFO per Share only applies to REITs.

MEX:FME N
48GF Score
Fresenius Medical Care AG MEX:FME N
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of MXN778.14 is trading 53.4% below its estimated GF Value™ of MXN1,670.07. GuruFocus considers Fresenius Medical Care AG to be Significantly Undervalued.

Key valuation signals for MEX:FME N:

  • FFO per Share:
  • GF Value™: MXN1,670.07 vs. price of MXN778.14 (53.4% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
48GF Score

Get the complete analysis for MEX:FME N

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN778.14
Price
MXN1,670.07
GF Value